Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Clarity Pharmaceuticals Ltd. ( (AU:CU6) ) has provided an update.
Clarity Pharmaceuticals Ltd. has experienced a change in the substantial holding of its shares by JPMorgan Chase & Co. and its affiliates. The voting power of JPMorgan has decreased from 7.33% to 6.09% due to various transactions involving securities lending and proprietary trading. This shift in shareholding could impact Clarity Pharmaceuticals’ market dynamics and influence investor perceptions, as changes in substantial holdings often reflect strategic moves by major stakeholders.
The most recent analyst rating on (AU:CU6) stock is a Buy with a A$6.10 price target. To see the full list of analyst forecasts on Clarity Pharmaceuticals Ltd. stock, see the AU:CU6 Stock Forecast page.
More about Clarity Pharmaceuticals Ltd.
Average Trading Volume: 2,988,354
Technical Sentiment Signal: Sell
Current Market Cap: A$810.1M
For detailed information about CU6 stock, go to TipRanks’ Stock Analysis page.